The Claim
In healthy adults aged 50–85, intermittent administration of 5 mg weekly compounded rapamycin over 48 weeks is associated with a likely improvement in self-reported general health, as measured by a mean increase of 5.88 points (95% CI: 1.35–10.42) on the SF-36 general health scale, suggesting a potential dose-specific benefit for perceived well-being.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Taking a low weekly dose of a drug called rapamycin for a year might make older adults feel healthier overall, based on their own reports.
See the scientific wording
Intermittent 5 mg weekly compounded rapamycin for 48 weeks likely improves self-reported general health in healthy adults aged 50–85, with a mean increase of 5.88 points (95% CI: 1.35–10.42) on the SF-36 general health scale, indicating a potential dose-specific benefit for perceived well-being.
What the research says
1 studyStudy: Influence of rapamycin on safety and healthspan metrics after one year: PEARL trial results
The study found that taking 5 mg of rapamycin once a week for a year improved how healthy people felt, which matches the claim.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.